News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
749,929 Results
Type
Article (45996)
Company Profile (367)
Press Release (703549)
Multimedia
Podcasts (103)
Webinars (19)
Section
Business (214959)
Career Advice (2151)
Deals (36848)
Drug Delivery (110)
Drug Development (83231)
Employer Resources (178)
FDA (17022)
Job Trends (15652)
News (361178)
Policy (34028)
Tag
Academia (2782)
Accelerated approval (14)
Adcomms (24)
Allergies (113)
Alliances (53327)
ALS (129)
Alzheimer's disease (1567)
Antibody-drug conjugate (ADC) (184)
Approvals (17072)
Artificial intelligence (402)
Autoimmune disease (40)
Automation (23)
Bankruptcy (367)
Best Places to Work (12168)
BIOSECURE Act (20)
Biosimilars (141)
Biotechnology (247)
Bladder cancer (113)
Brain cancer (40)
Breast cancer (421)
Cancer (3396)
Cardiovascular disease (279)
Career advice (1809)
Career pathing (34)
CAR-T (219)
CDC (40)
Cell therapy (579)
Cervical cancer (27)
Clinical research (68912)
Collaboration (1260)
Company closure (4)
Compensation (852)
Complete response letters (38)
COVID-19 (2763)
CRISPR (75)
C-suite (504)
Cystic fibrosis (126)
Data (3793)
Decentralized trials (2)
Denatured (43)
Depression (88)
Diabetes (399)
Diagnostics (6851)
Digital health (28)
Diversity (11)
Diversity, equity & inclusion (47)
Drug discovery (181)
Drug pricing (145)
Drug shortages (31)
Duchenne muscular dystrophy (176)
Earnings (91191)
Editorial (46)
Employer branding (22)
Employer resources (155)
Events (122010)
Executive appointments (946)
FDA (19243)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1111)
Gene editing (159)
Generative AI (33)
Gene therapy (460)
GLP-1 (875)
Government (4762)
Grass and pollen (6)
Guidances (333)
Healthcare (19927)
HIV (45)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (192)
Immuno-oncology (14)
Indications (47)
Infectious disease (2963)
Inflammatory bowel disease (169)
Inflation Reduction Act (11)
Influenza (81)
Intellectual property (168)
Interviews (337)
IPO (17140)
IRA (50)
Job creations (3890)
Job search strategy (1529)
Kidney cancer (13)
Labor market (64)
Layoffs (549)
Leadership (26)
Legal (8273)
Liver cancer (86)
Longevity (11)
Lung cancer (486)
Lymphoma (245)
Machine learning (22)
Management (62)
Manufacturing (532)
MASH (111)
Medical device (14469)
Medtech (14486)
Mergers & acquisitions (20532)
Metabolic disorders (975)
Multiple sclerosis (114)
NASH (16)
Neurodegenerative disease (163)
Neuropsychiatric disorders (38)
Neuroscience (2415)
NextGen: Class of 2025 (6957)
Non-profit (4757)
Now hiring (53)
Obesity (471)
Opinion (256)
Ovarian cancer (111)
Pain (146)
Pancreatic cancer (145)
Parkinson's disease (208)
Partnered (24)
Patents (380)
Patient recruitment (268)
Peanut (56)
People (61228)
Pharmaceutical (78)
Pharmacy benefit managers (21)
Phase I (21628)
Phase II (30335)
Phase III (22447)
Pipeline (2440)
Policy (239)
Postmarket research (2600)
Preclinical (9292)
Press Release (71)
Prostate cancer (168)
Psychedelics (39)
Radiopharmaceuticals (276)
Rare diseases (548)
Real estate (6366)
Recruiting (66)
Regulatory (24068)
Reports (52)
Research institute (2536)
Resumes & cover letters (363)
Rett syndrome (11)
RNA editing (14)
RSV (56)
Schizophrenia (111)
Series A (182)
Series B (137)
Service/supplier (18)
Sickle cell disease (74)
Special edition (21)
Spinal muscular atrophy (168)
Sponsored (36)
Startups (3918)
State (2)
Stomach cancer (14)
Supply chain (89)
Tariffs (75)
The Weekly (58)
Vaccines (902)
Venture capital (61)
Weight loss (301)
Women's health (54)
Worklife (18)
Date
Last 7 days (508)
Last 30 days (2162)
Last 365 days (31963)
2025 (22660)
2024 (36742)
2023 (41632)
2022 (52917)
2021 (57566)
2020 (56190)
2019 (49212)
2018 (37144)
2017 (34089)
2016 (33849)
2015 (40053)
2014 (33571)
2013 (28566)
2012 (30794)
2011 (31375)
2010 (29281)
Location
Africa (789)
Alabama (72)
Alaska (7)
Arizona (275)
Arkansas (14)
Asia (42115)
Australia (6946)
California (8789)
Canada (2698)
China (821)
Colorado (370)
Connecticut (387)
Delaware (238)
Europe (93224)
Florida (1297)
Georgia (301)
Hawaii (2)
Idaho (64)
Illinois (731)
India (43)
Indiana (418)
Iowa (18)
Japan (267)
Kansas (119)
Kentucky (32)
Louisiana (18)
Maine (65)
Maryland (1160)
Massachusetts (6561)
Michigan (290)
Minnesota (533)
Mississippi (4)
Missouri (110)
Montana (32)
Nebraska (25)
Nevada (101)
New Hampshire (75)
New Jersey (2424)
New Mexico (31)
New York (2402)
North Carolina (1301)
North Dakota (10)
Northern California (3955)
Ohio (269)
Oklahoma (19)
Oregon (39)
Pennsylvania (1846)
Puerto Rico (18)
Rhode Island (42)
South America (1185)
South Carolina (45)
South Dakota (1)
Southern California (3374)
Tennessee (141)
Texas (1359)
United States (32354)
Utah (266)
Virginia (217)
Washington D.C. (79)
Washington State (740)
West Virginia (4)
Wisconsin (87)
749,929 Results for "innovative spinal technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Spinal muscular atrophy
6 Therapies on the Horizon for Spinal Muscular Atrophy
Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through clinical trials.
March 24, 2025
·
5 min read
·
Natalia Mesa
Policy
Providence Medical Technology, Inc. Announces FDA Clearance of CORUS™ Navigation Access System for Use with Medtronic’s StealthStation™ Surgical Navigation in Posterior Spinal Fusion
Providence Medical Technology, Inc., an innovator in solutions for spinal surgery, announces that the U.S. Food and Drug Administration has cleared the use of the CORUS™ Navigation Access System for use with the CORUS Spinal System during spinal surgery.
June 13, 2024
·
4 min read
Press Releases
Ruthless Spine Announces Intellectual Property News and 510(k) Clearance on Revolutionary Spinal Instrument
September 18, 2025
·
4 min read
Press Releases
Spinal Resources Inc. Announces Publication in Spine Deformity of Impact of a Novel Patient-Specific, Patient-Matched Bezier Parametric Curve Rod Platform on Proximal Junction Biomechanics in an in Silico Thoracolumbar Fusion Model
August 1, 2025
·
3 min read
Press Releases
OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
September 10, 2025
·
2 min read
Press Releases
Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury
September 16, 2025
·
5 min read
Press Releases
Modeling Spinal Muscular Atrophy to Identify a Promising Therapy
August 6, 2025
·
1 min read
Press Releases
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
September 8, 2025
·
6 min read
Press Releases
ulrich medical USA® Announces Full Market Launch of Cortium® Universal OCT Spinal Fixation System
August 8, 2025
·
2 min read
Press Releases
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
September 18, 2025
·
8 min read
1 of 74,993
Next
